参考文献/References:
[1] Montero-Cabezas JM,Abou R,Chimed S,et al. Effects of atrial ischemia on left atrial remodeling in patients with ST-segment elevation myocardial infarction[J]. J Am Soc Echocardiogr,2023,36(2):163-171.
[2] Hoit BD. Left atrial size and function:role in prognosis[J]. J Am Coll Cardiol,2014,63(6):493-505.
[3] Inoue K,Kawakami H,Akazawa Y,et al. Echocardiographic assessment of atrial function:from basic mechanics to specific cardiac diseases[J]. J Cardiovasc Dev Dis,2022,9(3):68.
[4] Gensini GG,Buonanno C,Palacio A. Anatomy of the coronary circulation in living man. Coronary arteriography[J]. Dis Chest,1967,52(2):125-140.
[5] Thomas L,Abhayaratna WP. Left atrial reverse remodeling:mechanisms,evaluation,and clinical significance[J]. JACC Cardiovasc Imaging,2017,10(1):65-77.
[6] Caturano A,Vetrano E,Galiero R,et al. Cardiac hypertrophy:from pathophysiological mechanisms to heart failure development[J]. Rev Cardiovasc Med,2022,23(5):165.
[7] Hu YF,Yeh HI,Tsao HM,et al. Electrophysiological correlation and prognostic impact of heat shock protein 27 in atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2012,5(2):334-340.
[8] Petrucci G,Rizzi A,Hatem D,et al. Role of oxidative stress in the pathogenesis of atherothrombotic diseases[J]. Antioxidants(Basel),2022,11(7):1408.
[9] Hartley B,Bassiouni W,Schulz R,et al. The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury[J]. Basic Res Cardiol,2023,118(1):38.
[10] Xintarakou A,Tzeis S,Psarras S,et al. Atrial fibrosis as a dominant factor for the development of atrial fibrillation:facts and gaps[J]. Europace,2020,22(3):342-351.
[11] Li M,Ning Y,Tse G,et al. Atrial cardiomyopathy:from cell to bedside[J]. ESC Heart Fail,2022,9(6):3768-3784.
[12] Triposkiadis F,Pieske B,Butler J,et al. Global left atrial failure in heart failure[J]. Eur J Heart Fail,2016,18(11):1307-1320.
[13] Bozkurt E,Arslan S,Acikel M,et al. Left atrial remodeling in acute anterior myocardial infarction[J]. Echocardiography,2007,24(3):243-251.
[14] Grafton-Clarke C,Garg P,Swift AJ,et al. Cardiac magnetic resonance left ventricular filling pressure is linked to symptoms,signs and prognosis in heart failure[J]. ESC Heart Fail,2023,10(5):3067-3076.
[15] Russo C,Hahn RT,Jin Z,et al. Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography[J]. J Am Soc Echocardiogr,2010,23(9):954-960.
[16] Park SM,Kim KC,Jeon MJ,et al. Assessment of left ventricular asynchrony using volume-time curves of 16 segments by real-time 3 dimensional echocardiography:comparison with tissue Doppler imaging[J]. Eur J Heart Fail,2007,9(1):62-67.
[17] Kawel-Boehm N,Bremerich J. The Importance of left atrial function after myocardial infarction[J]. Radiology,2020,296(2):310-311.
[18] Yoon YE,Oh IY,Kim SA,et al. Echocardiographic predictors of progression to persistent or permanent atrial fibrillation in patients with paroxysmal atrial fibrillation (E6P Study)[J]. J Am Soc Echocardiogr,2015,28(6):709-717.
[19] López-Galvez R,Rivera-Caravaca JM,Roldán V,et al. Imaging in atrial fibrillation:a way to assess atrial fibrosis and remodeling to assist decision-making[J]. Am Heart J,2023,258:1-16.
[20] Chaudhuri AA,Simmons C Jr,Ellison D,et al. Atrial myxoma presenting as myocardial infarction diagnosed by echocardiography,managed endoscopically with robot-assisted surgery[J]. Cureus,2016,8(2):e484.
[21] Gruca MM,Slivnick JA,Singh A,et al. Noninvasive assessment of left ventricular end-diastolic pressure using machine learning-derived phasic left atrial strain[J]. Eur Heart J Cardiovasc Imaging,2023,25(1):18-26.
[22] Jiang B,Guo N,Ge Y,et al. Development and application of artificial intelligence in cardiac imaging[J]. Br J Radiol,2020,93(1113):20190812.
[23] Legallois D,Hodzic A,Milliez P,et al. Left atrial strain quantified after myocardial infarction is associated with early left ventricular remodeling[J]. Echocardiography,2022,39(12):1581-1588.
[24] Hoshida S,Tachibana K,Shinoda Y,et al. Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction[J]. ESC Heart Failure,2022,9(3):1784-1791.
[25] Jin X,Nauta JF,Hung CL,et al. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF):systematic review and meta-analysis[J]. Heart Fail Rev,2022,27(5):1933-1955.
[26] Petersen JK,Butt JH,Yafasova A,et al. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation:a nationwide study[J]. Eur Heart J,2021,42(44):4553-4561.
[27] Luo J,Xu S,Li H,et al. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure[J]. ESC Heart Fail,2020,7(5):2762-2772.
[28] ?amc? S,Ar? H,Ar? S,et al. The predictive value of the left atrial kinetic energy for atrial fibrillation recurrence[J]. Cureus,2022,14(9):e28714.
[29] Vahanian A,Beyersdorf F,Praz F,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J,2022,43(7):561-632.
[30] Byrne RA,Rossello X,Coughlan JJ,et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J,2023,44(38):3720-3826.
[31] McDonagh TA,Metra M,Adamo M,et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2023,44(37):3627-3639.
[32] Zhu T,Zhang W,Yang Q,et al. Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation[J]. Front Cardiovasc Med,2022,9:1048077.
[33] Chen YC,Voskoboinik A,Gerche A,et al. Prevention of pathological atrial remodeling and atrial fibrillation:JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,77(22):2846-2864.
[34] 徐敏,刘飞,葛志翔,等. 阵发性心房颤动患者环肺静脉射频消融术后复发的预测因素研究[J]. 中华医学超声杂志（电子版）,2020,17(12):1220-1226.
[35] Damluji AA,van Diepen S,Katz JN,et al. Mechanical complications of acute myocardial infarction:A Scientific Statement From the American Heart Association[J]. Circulation,2021,144(2):e16-e35.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(5):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(5):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(5):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(5):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(5):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(5):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(5):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]